Wendi Hu

1.4k total citations · 1 hit paper
23 papers, 1.0k citations indexed

About

Wendi Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wendi Hu has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Wendi Hu's work include RNA modifications and cancer (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Wendi Hu is often cited by papers focused on RNA modifications and cancer (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Wendi Hu collaborates with scholars based in China, Madagascar and United States. Wendi Hu's co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Chuanhui Peng, Junru Chen, Yunhao Chen, Lin Zhou, Beng Yang, Bin He and Yanpeng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Wendi Hu

22 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

2019 479 citations Yunhao Chen, Chuanhui Peng et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendi Hu China	14	835	577	143	141	69	23	1.0k
Jieyi Ma China	20	1.1k 1.3×	656 1.1×	117 0.8×	171 1.2×	41 0.6×	37	1.3k
Yongqian Shu China	16	658 0.8×	347 0.6×	88 0.6×	135 1.0×	33 0.5×	22	773
Runping Fang China	18	733 0.9×	403 0.7×	70 0.5×	154 1.1×	31 0.4×	26	943
Yuejie Lu China	9	545 0.7×	428 0.7×	104 0.7×	71 0.5×	26 0.4×	15	678
Jiangtao Cui China	16	727 0.9×	505 0.9×	423 3.0×	95 0.7×	38 0.6×	31	997
Shunjie Xia China	9	534 0.6×	399 0.7×	98 0.7×	86 0.6×	18 0.3×	13	731
Yuqing Zhang China	15	604 0.7×	553 1.0×	44 0.3×	119 0.8×	21 0.3×	25	848
Jiang Shi China	14	619 0.7×	446 0.8×	69 0.5×	75 0.5×	21 0.3×	25	753
Jingnan Shen China	17	939 1.1×	663 1.1×	160 1.1×	206 1.5×	12 0.2×	31	1.2k

Countries citing papers authored by Wendi Hu

Since Specialization

Citations

This map shows the geographic impact of Wendi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendi Hu more than expected).

Fields of papers citing papers by Wendi Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendi Hu. The network helps show where Wendi Hu may publish in the future.

Co-authorship network of co-authors of Wendi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wendi Hu. A scholar is included among the top collaborators of Wendi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendi Hu. Wendi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaoyu, Wei Chen, Xiang Li, et al.. (2025). Robotic pancreatoduodenectomy reduces grade B pancreatic fistula in patients with a small main pancreatic duct: a propensity score-matched study compared to laparoscopic pancreatoduodenectomy. Annals of Medicine. 57(1). 2527357–2527357.

Chen, Yiwen, Wendi Hu, Xiang Li, et al.. (2024). Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study. Signal Transduction and Targeted Therapy. 9(1). 280–280. 6 indexed citations

Bai, Xueli, Wendi Hu, Xiang Li, et al.. (2024). Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular carcinoma: An open-label, single-arm, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 4108–4108. 1 indexed citations

Liang, Tingbo, Yiwen Chen, Wendi Hu, et al.. (2023). Efficacy and safety of envafolimab plus lenvatinib combined with TACE in unresectable hepatocellular carcinoma: An open-label, single-arm, phase 2 study—The CISLD-12 study.. Journal of Clinical Oncology. 41(4_suppl). 558–558. 3 indexed citations

Dong, Yahao, Yanan Wang, Xinjuan Li, et al.. (2022). Palladium supported on pyrrole functionalized hypercrosslinked polymer: Synthesis and its catalytic evaluations towards Suzuki-Miyaura coupling reactions in aqueous media. Journal of Molecular Liquids. 368. 120679–120679. 18 indexed citations

Li, Duguang, Junhai Pan, Yiyin Zhang, et al.. (2022). C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11. Cancers. 14(14). 3410–3410. 18 indexed citations

Wei, Shuang, Yun Sun, Li Wang, et al.. (2021). Hyperoside suppresses BMP-7-dependent PI3K/AKT pathway in human hepatocellular carcinoma cells. Annals of Translational Medicine. 9(15). 1233–1233. 19 indexed citations

Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Letters. 502. 154–165. 162 indexed citations

Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis. Oncogenesis. 9(4). 42–42. 71 indexed citations

10.

Chen, Yunhao, Chuanhui Peng, Junru Chen, et al.. (2019). WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Molecular Cancer. 18(1). 127–127. 479 indexed citations breakdown →

11.

Hu, Wendi, Zhen Lv, Hua Liu, et al.. (2019). PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology. 44(2). 162–173. 25 indexed citations

12.

Weng, Xiaoyu, Jingbang Wu, Zhen Lv, et al.. (2019). Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5. EBioMedicine. 44. 225–236. 24 indexed citations

13.

Dai, Longfei, Wendi Hu, Diyu Chen, et al.. (2019). Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Laboratory Investigation. 99(6). 736–748. 16 indexed citations

14.

Chen, Ronggao, Yiting Qiao, Wendi Hu, et al.. (2019). LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.. PubMed. 9(10). 2216–2232. 3 indexed citations

15.

Sun, Weijian, Bin He, Beng Yang, et al.. (2018). Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Laboratory Investigation. 98(6). 734–744. 42 indexed citations

16.

Peng, Chuanhui, Wendi Hu, Xiaoyu Weng, et al.. (2017). Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8. Scientific Reports. 7(1). 4186–4186. 28 indexed citations

17.

Sun, Weijian, Bin He, Beng Yang, et al.. (2017). Autophagy blockade enhances the anti-cancer effect of Romidepsin in gastric cancer. Translational Cancer Research. 6(6). 1313–1320. 1 indexed citations

18.

Li, Yatong, Menghua Dai, Xiaoyan Chang, et al.. (2016). Mixed serous neuroendocrine neoplasm of the pancreas. Medicine. 95(34). e4205–e4205. 6 indexed citations

19.

Cheng, Shaobing, Xu Jiang, Chaofeng Ding, et al.. (2016). Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 17(8). 1373–1373. 28 indexed citations

20.

Du, Chengli, Xiaoyu Weng, Wendi Hu, et al.. (2015). Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 67–67. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact